The role of mitochondrial uncoupling in 3,4-methylenedioxymethamphetamine- mediated skeletal muscle hyperthermia and rhabdomyolysis

Journal of Pharmacology and Experimental Therapeutics

Volumn 313, Issue 2, 2005, Pages 629-639

  Rusyniak, Daniel E ^a,e   Tandy, Stephany L ^a   Hekmatyar, S K ^a   Mills, Edward ^b   Smith, David J ^a   Bansal, Navin ^a   MacLellan, Darcy ^c   Harper, Mary Ellen ^c   Sprague, Jon E ^d  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c UNIVERSITY OF OTTAWA   (Canada)

^d EDWARD VIA COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

^e REGENSTRIEF INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; CREATINE KINASE; PHOSPHATE; UNCOUPLING PROTEIN; UNCOUPLING PROTEIN 3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOENERGY; CELL PH; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; HYPERTHERMIA; MALE; MUSCLE FIBRIL; MUSCLE MITOCHONDRION; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTEIN INTERACTION; RAT; RHABDOMYOLYSIS; SKELETAL MUSCLE;

ANIMALS; CARRIER PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEVER; ION CHANNELS; MALE; MEMBRANE PROTEINS; MITOCHONDRIA, MUSCLE; MITOCHONDRIAL PROTEINS; MUSCLE, SKELETAL; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; RATS; RATS, SPRAGUE-DAWLEY; RHABDOMYOLYSIS; UNCOUPLING AGENTS;

EID: 18044361956     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.104.079236     Document Type: Article

References (48)

1. Badon LA, Hicks A, Lord K, Ogden BA, Meleg-Smith S, and Varner KJ (2002) Changes in cardiovascular responsiveness and cardiotoxicity elicited during binge administration of Ecstasy. J Pharmacol Exp Ther 302:898-907.
2. Boss O, Samec S, Paoloni-Giacobino A, Rossier C, Dulloo A, Seydoux J, Muzzin P, and Giacobino JP (1997) Uncoupling protein-3: a new member of the mitochondrial carrier family with tissue-specific expression. FEBS Lett 408:39-42.
3. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
4. Byrne E, Hayes DJ, Shoubridge EA, Morgan-Hughes JA, and Clark JB (1985) Experimentally induced defects of mitochondrial metabolism in rat skeletal muscle. Biological effects of the mitochondrial uncoupling agent 2,4-dinitrophenol. Biochem J 229:101-108.
5. Chan P, Di Monte DA, Luo J-J, DeLanney LE, Irwin I, and Langston JW (1994) Rapid ATP loss caused by methamphetamine in the mouse striatum: relationship between energy impairment and dopaminergic neurotoxicity. J Neurochem 62:2484-2487.
6. Curry SC, Chang D, and Connor D (1989) Drug- and toxin-induced rhabdomyolysis. Ann Emerg Med 18:1068-1084.
7. Dar KJ and McBrien ME (1996) MDMA induced hyperthermia: report of a fatality and review of current therapy. Intensive Care Med 22:995-996.
8. Darvesh AS, Shankaran M, and Gudelsky GA (2002) 3,4- Methylenedioxymethamphetamine produces glycogenolysis and increases the extracellular concentration of glucose in the rat brain. J Pharmacol Exp Ther 301:138-144.
9. de Jesus LA, Carvalho SD, Ribeiro MO, Schneider M, Kim SW, Harney JW, Larsen PR, and Bianco AC (2001) The type 2 iodothyronine deiodinase is essential for adaptive thermogenesis in brown adipose tissue. J Clin Investig 108:1379-1385.
10. Duarte JA, Leao A, Magalhaes J, Ascensao A, Bastos ML, Amado FL, Vilarinho L, Quelhas D, Appell HJ, and Carvalho F (2005) Strenuous exercise aggravates MDMA-induced skeletal muscle damage in mice. Toxicology 206:349-358.
11. Estabrook RW (1967) Mitochondrial respiratory control and the polarographic measurement of ADP/O ratios. Methods Enzymol 10:41-47.
12. Fahal IH, Sallomi DF, Yaqoob M, and Bell GM (1992) Acute renal failure after ecstasy. Br Med J 305:29.
13. Gong DW, He Y, Karas M, and Reitman M (1997) Uncoupling protein-3 is a mediator of thermogenesis regulated by thyroid hormone, beta3-adrenergic agonists and leptin. J Biol Chem 272:24129-24132.
14. Gordon CJ, Watkinson WP, O'Callaghan JP, and Miller DB (1991) Effects of 3,4-methylenedioxymethamphetamine on autonomic thermoregulatory responses of the rat. Pharmacol Biochem Behav 38:339-344.
15. Gowing LR, Henry-Edwards SM, Irvine RJ, and Ali RL (2002) The health effects of ecstasy: a literature review. Drug Alcohol Rev 21:53-63.
16. Green CE, LeValley SE, and Tyson CA (1986) Comparison of amphetamine metabolism using isolated hepatocytes from five species including human. J Pharmacol Exp Ther 237:931-936.
17. Jucker BM, Dufour S, Ren J, Cao X, Previs SF, Underhill B, Cadman KS, and Shulman GI (2000) Assessment of mitochondrial energy coupling in vivo by 13C/31P NMR. Proc Natl Acad Sci USA 97:6880-6884.
18. Kato I, Harihara A, and Mizushima Y (1992) An in vitro model for assessing muscle irritation of antibiotics using rat primary cultured skeletal muscle fibers. Toxicol Appl Pharmacol 117:194-199.
19. Kendrick WC, Hull AR, and Knochel JP (1977) Rhabdomyolysis and shock after intravenous amphetamine administration. Ann Intern Med 86:381-387.
20. Kerner J, Turkaly PJ, Minkler PE, and Hoppel CL (2001) Aging skeletal muscle mitochondria in the rat: decreased uncoupling protein-3 content. Am J Physiol 281:E1054-E1062.
21. Larrouy D, Laharrague P, Carrera G, Viguerie-Bascands N, Levi-Meyrueis C, Fleury C, Pecqueur C, Nibbelink M, Andre M, Casteilla L, et al. (1997) Kupffer cells are a dominant site of uncoupling protein 2 expression in rat liver. Biochem Biophys Res Commun 235:760-764.
22. Leftwich RB, Floro JF, Neal RA, and Wood AJ (1982) Dinitrophenol poisoning: a diagnosis to consider in undiagnosed fever. South Med J 75:182-184.
23. Lim HK and Foltz RL (1988) In vivo and in vitro metabolism of 3,4-(methylenedioxy) methamphetamine in the rat: identification of metabolites using an ion trap detector. Chem Res Toxicol 1:370-378.
24. Maglara AA, Vasilaki A, Jackson MJ, and McArdle A (2003) Damage to developing mouse skeletal muscle myotubes in culture: protective effect of heat shock proteins. J Physiol 548:837-846.
25. Makisumi T, Yoshida K, Watanabe T, Tan N, Murakami N, and Morimoto A (1998) Sympatho-adrenal involvement in methamphetamine-induced hyperthermia through skeletal muscle hypermetabolism. Eur J Pharmacol 363:107-112.
26. Makos JD, Malloy CR, and Sherry AD (1998) Distribution of TmDOTP5- in rat tissues: TmDOTP5- vs. CoEDTA- as markers of extracellular tissue space. J Appl Physiol 85:1800-1805.
27. Mills EM, Banks ML, Sprague JE, and Finkel T (2003) Uncoupling the agony from ecstasy. Nature (Lond) 426:403-404.
28. Morley JE and Shafer RB (1982) Thyroid function screening in new psychiatric admissions. Arch Intern Med 142:591-593.
29. Nagase I, Yoshida S, Canas X, Irie Y, Kimura K, Yoshida T, and Saito M (1999) Up-regulation of uncoupling protein 3 by thyroid hormone, peroxisome proliferator-activated receptor ligands and 9-cis retinoic acid in L6 myotubes. FEBS Lett 461:319-322.
30. Nagase I, Yoshida T, and Saito M (2001) Up-regulation of uncoupling proteins by beta-adrenergic stimulation in L6 myotubes. FEBS Lett 494:175-180.
31. Nahorski SR and Rogers KJ (1973) In vivo effects of amphetamine on metabolites and metabolic rate in brain. J Neurochem 21:679-686.
32. Neville C, Rosenthal N, McGrew M, Bogdanova N, and Hauschka S (1997) Skeletal muscle cultures. Methods Cell Biol 52:85-116.
33. Nicholls DG and Locke RM (1984) Thermogenic mechanisms in brown fat. Physiol Rev 64:1-64.
34. Nowak TS Jr (1988) Effects of amphetamine on protein synthesis and energy metabolism in mouse brain: role of drug-induced hyperthermia. J Neurochem 50:285-294.
35. O'Callaghan J and Miller D (1994) Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mouse. J Pharmacol Exp Ther 270:741-751.
36. Pedersen NP and Blessing WW (2001) Cutaneous vasoconstriction contributes to hyperthermia induced by 3,4-methylenedioxymethamphetamine (ecstasy) in conscious rabbits. J Neurosci 21:8648-8654.
37. Ravina P, Quiroga JM, and Ravina T (2004) Hyperkalemia in fatal MDMA ('ecstasy') toxicity. Int J Cardiol 93:307-308.
38. Richards JR, Johnson EB, Stark RW, and Derlet RW (1999) Methamphetamine abuse and rhabdomyolysis in the ED: a 5-year study. Am J Emerg Med 17:681-685.
39. Rusyniak DE, Tandy SL, Kamendulis LM, Sprague JE, and Klaunig JE (2004) The effects of ecstasy (MDMA) on rat liver bioenergetics. Acad Emerg Med 11:723-729.
40. Seglen O (1993) Isolation of hepatocytes by collagenase perfusion, in Methods in Toxicology (Tyson CA and Frazier JM eds) pp 231-231, Academic Press, New York.
41. Skulachev VP (1998) Uncoupling: new approaches to an old problem of bioenergetics. Biochim Biophys Acta 1363:100-124.
42. Sprague JE, Banks ML, Cook VJ, and Mills EM (2003) Hypothalamic- pituitary-thyroid axis and sympathetic nervous system involvement in hyperthermia induced by 3,4-methylenedioxymethamphetamine (Ecstasy). J Pharmacol Exp Ther 305:159-166.
43. Stephans SE, Whittingham TS, Douglas AJ, Lust WD, and Yamamoto BK (1998) Substrates of energy metabolism attenuate methamphetamine-induced neurotoxicity in striatum. J Neurochem 71:613-621.
44. Stuerenburg HJ, Petersen K, Baumer T, Rosenkranz M, Buhmann C, and Thomasius R (2002) Plasma concentrations of 5-HT, 5-HIAA, norepinephrine, epinephrine and dopamine in ecstasy users. Neuro Endocrinol Lett 23:259-261.
45. Teruel T, Smith SA, Peterson J, and Clapham JC (2000) Synergistic activation of UCP-3 expression in cultured fetal rat brown adipocytes by PPARalpha and PPARgamma ligands. Biochem Biophys Res Commun 273:560-564.
46. Zaninovich AA, Rebagliati I, Raices M, Ricci C, and Hagmuller K (2003) Mitochondrial respiration in muscle and liver from cold-acclimated hypothyroid rats. J Appl Physiol 95:1584-1590.
47. Zhao J, Cannon B, and Nedergaard J (1997) Alpha 1-adrenergic stimulation potentiates the thermogenic action of beta 3-adrenoreceptor-generated cAMP in brown fat cells. J Biol Chem 272:32847-32856.
48. Zychlinski L and Montgomery MR (1985) Chlorphentermine-induced biochemical alterations in mitochondrial membranes. J Pharmacol Exp Ther 233:39-44.